Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HELMEDICA ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.3% 3.3%   Bankruptcy risk   6.0% 4.3% 6.0% 11.5% 9.2% 7.2% 18.0% 18.0%   Credit score (0-100)   40 49 39 20 26 33 8 8   Credit rating   BBB BBB BBB BB BB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   168 154 21.4 -44.0 -17.9 53.0 0.0 0.0   EBITDA   99.4 106 -12.6 -74.7 -48.6 -4.0 0.0 0.0   EBIT   91.8 92.5 -26.8 -81.2 -56.1 -11.5 0.0 0.0   Pre-tax profit (PTP)   25.5 124.3 -10.7 -23.7 -24.7 -18.1 0.0 0.0   Net earnings   19.9 90.4 -8.3 -19.6 -21.0 -39.1 0.0 0.0   Pre-tax profit without non-rec. items   25.5 124 -10.7 -23.7 -24.7 -18.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   22.8 25.5 11.4 26.4 18.9 11.3 0.0 0.0   Shareholders equity total   145 225 157 137 116 77.3 -47.7 -47.7   Interest-bearing liabilities   116 76.5 198 109 141 144 47.7 47.7   Balance sheet total (assets)   297 341 385 289 295 280 0.0 0.0   Net Debt   -58.8 -143 -48.2 -49.6 -48.3 -45.4 47.7 47.7     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   168 154 21.4 -44.0 -17.9 53.0 0.0 0.0   Gross profit growth   -26.2% -8.5% -86.1% 0.0% 59.3% 0.0% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   297 341 385 289 295 280 0 0   Balance sheet change%   -22.2% 14.8% 12.9% -24.8% 2.0% -5.0% -100.0% 0.0%   Added value   99.4 106.0 -12.6 -74.7 -49.6 -4.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -15 -11 -28 9 -15 -15 -11 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   54.7% 60.2% -125.4% 184.4% 313.3% -21.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   28.8% 41.6% -0.6% -5.5% -6.1% -2.4% 0.0% 0.0%   ROI %   33.5% 47.2% -0.7% -6.2% -7.0% -2.8% 0.0% 0.0%   ROE %   11.0% 48.8% -4.3% -13.3% -16.5% -40.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   48.8% 66.1% 40.8% 47.5% 39.4% 27.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -59.1% -135.1% 383.1% 66.4% 99.5% 1,139.6% 0.0% 0.0%   Gearing %   80.0% 34.0% 126.4% 79.6% 120.7% 186.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   64.9% 8.7% 6.2% 3.3% 5.4% 7.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.8 2.7 1.6 1.7 1.6 1.4 0.0 0.0   Current Ratio   1.8 2.7 1.6 1.7 1.6 1.4 0.0 0.0   Cash and cash equivalent   174.7 219.7 246.7 159.0 188.9 189.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -52.6 -20.0 -100.9 -47.5 -86.7 -118.2 -23.8 -23.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   99 106 -13 -75 -50 -4 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   99 106 -13 -75 -49 -4 0 0   EBIT / employee   92 92 -27 -81 -56 -12 0 0   Net earnings / employee   20 90 -8 -20 -21 -39 0 0